CRY1

Across TCGA pan-cancer cohorts, CRY1 Mutation is linked to patient survival in 2 of 34 cancer types, making it a survival-associated CRY1 data layer compared with 28 for mass-spec protein and 2 for mass-spec protein.

The strongest signal is observed in ovarian serous cystadenocarcinoma (OV), where higher CRY1 Mutation is associated with worse overall survival. In most high-consensus cancer types, elevated CRY1 expression acts as an unfavorable survival marker.

OV and READ are the cancer types where CRY1 Mutation most reproducibly stratifies survival.

Mutation survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
OV	OS	Median	II,III,IV	0.397	0.693	.007	18	view →
READ	DFS	Median	All	0.182	0.798	.010	9	view →

Pink = unfavorable, green = favorable. Showing the 2 strongest of 2 lineages.

CRY1–OV (OS)

Open the OV breakdown →